Decoy Therapeutics Stock Forecast

DCOY's stock price has decreased by -95.85% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Decoy Therapeutics stock has a target of 30, which predicts an increase of 447.95% from the current stock price of 5.48.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$30	$30	$30
Change	+447.95%	+447.95%	+447.95%	+447.95%

* Price targets were last updated on Jan 23, 2026.

Analyst Ratings

According to 1 stock analyst, the rating for Decoy Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Mar '26	Apr '26
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Kevin DeGeeter Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $30	Strong Buy	Initiates	$30	+447.95%	Jan 23, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

12.11M

Revenue Next Year

n/a

from 12.11M

EPS This Year

n/a

from -129.10

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.84M	-	-	-	-	12.11M
Revenue Growth	-64.84%	-	-	-	-	-
EPS	-	-	-	-69.54	-129.10	-
EPS Growth	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026
High	12.5M
Avg	12.1M
Low	11.6M

Revenue Growth

Revenue Growth	2026
High	-
Avg	-
Low	-

EPS Forecast

EPS
High
Avg
Low

EPS Growth

EPS Growth
High
Avg
Low

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.